Drug · DIN 02278464
DOM-RISPERIDONE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 30, 2025; first marketed August 8, 2006.
- Drug Identification Number (DIN)
- 02278464
- Company (DIN owner)
- Dominion PharmacalMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- August 15, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 2.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 27, 2006: NOC 8176Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named DOM-RISPERIDONE
- DIN 02278421 · Cancelled Post Market
- DIN 02278448 · Cancelled Post Market
- DIN 02278456 · Cancelled Post Market
- DIN 02278472 · Cancelled Post Market
- DIN 02278480 · Cancelled Post Market
- DIN 02309572 · Cancelled Pre Market